List of Excipients in API budesonide and formoterol fumarate dihydrate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing budesonide and formoterol fumarate dihydrate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | SYMBICORT | budesonide and formoterol fumarate dihydrate | 0186-0370 | APAFLURANE | |
| AstraZeneca Pharmaceuticals LP | SYMBICORT | budesonide and formoterol fumarate dihydrate | 0186-0370 | POLYETHYLENE GLYCOL 1000 | |
| AstraZeneca Pharmaceuticals LP | SYMBICORT | budesonide and formoterol fumarate dihydrate | 0186-0370 | POVIDONE K25 | |
| AstraZeneca Pharmaceuticals LP | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | budesonide and formoterol fumarate dihydrate | 0310-7370 | APAFLURANE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for budesonide and formoterol fumarate dihydrate
Excipient focus: APAFLURANE
budesonide and formoterol fumarate dihydrate drug variants containing APAFLURANE
budesonide and formoterol fumarate dihydrate drug variants not containing APAFLURANE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1000
budesonide and formoterol fumarate dihydrate drug variants containing POLYETHYLENE GLYCOL 1000
budesonide and formoterol fumarate dihydrate drug variants not containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
budesonide and formoterol fumarate dihydrate drug variants containing POVIDONE K25
budesonide and formoterol fumarate dihydrate drug variants not containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
